Activest Wealth Management Has $33,000 Stock Position in Synopsys, Inc. $SNPS

Activest Wealth Management trimmed its stake in shares of Synopsys, Inc. (NASDAQ:SNPS) by 38.5% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 64 shares of the semiconductor company’s stock after selling 40 shares during the quarter. Activest Wealth Management’s holdings in Synopsys were worth $33,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors also recently added to or reduced their stakes in the stock. Cornerstone Planning Group LLC boosted its holdings in shares of Synopsys by 275.0% in the 1st quarter. Cornerstone Planning Group LLC now owns 60 shares of the semiconductor company’s stock worth $25,000 after acquiring an additional 44 shares in the last quarter. Saudi Central Bank acquired a new position in shares of Synopsys in the 1st quarter worth approximately $26,000. Clal Insurance Enterprises Holdings Ltd boosted its holdings in shares of Synopsys by 441.7% in the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 65 shares of the semiconductor company’s stock worth $28,000 after acquiring an additional 53 shares in the last quarter. Independence Bank of Kentucky boosted its holdings in shares of Synopsys by 120.0% in the 2nd quarter. Independence Bank of Kentucky now owns 55 shares of the semiconductor company’s stock worth $28,000 after acquiring an additional 30 shares in the last quarter. Finally, WPG Advisers LLC acquired a new position in shares of Synopsys in the 1st quarter worth approximately $34,000. 85.47% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several research analysts have recently commented on the company. Wells Fargo & Company reduced their target price on Synopsys from $630.00 to $550.00 and set an “equal weight” rating on the stock in a report on Wednesday, September 10th. Zacks Research downgraded Synopsys from a “hold” rating to a “strong sell” rating in a report on Friday, September 12th. BNP Paribas initiated coverage on Synopsys in a report on Thursday, October 2nd. They issued an “underperform” rating and a $425.00 target price on the stock. The Goldman Sachs Group reduced their price objective on Synopsys from $700.00 to $600.00 and set a “buy” rating on the stock in a report on Wednesday, September 10th. Finally, Wall Street Zen downgraded Synopsys from a “hold” rating to a “sell” rating in a report on Saturday, September 13th. Ten analysts have rated the stock with a Buy rating, five have assigned a Hold rating and four have given a Sell rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $569.67.

Insider Buying and Selling at Synopsys

In other Synopsys news, CFO Shelagh Glaser sold 3,655 shares of the company’s stock in a transaction on Friday, September 5th. The shares were sold at an average price of $609.77, for a total transaction of $2,228,709.35. Following the completion of the sale, the chief financial officer owned 15,317 shares in the company, valued at approximately $9,339,847.09. The trade was a 19.27% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CAO Sudhindra Kankanwadi sold 9,873 shares of the company’s stock in a transaction on Monday, September 22nd. The shares were sold at an average price of $500.90, for a total transaction of $4,945,385.70. Following the sale, the chief accounting officer owned 20,520 shares of the company’s stock, valued at $10,278,468. The trade was a 32.48% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 30,894 shares of company stock worth $16,760,783. 0.62% of the stock is currently owned by insiders.

Synopsys Stock Up 1.0%

NASDAQ:SNPS opened at $440.20 on Friday. The stock’s fifty day moving average price is $529.15 and its two-hundred day moving average price is $510.15. Synopsys, Inc. has a 52-week low of $365.74 and a 52-week high of $651.73. The company has a debt-to-equity ratio of 0.52, a quick ratio of 1.51 and a current ratio of 1.62. The company has a market cap of $81.77 billion, a price-to-earnings ratio of 34.55, a P/E/G ratio of 4.80 and a beta of 1.10.

Synopsys (NASDAQ:SNPS) last issued its earnings results on Tuesday, September 9th. The semiconductor company reported $2.30 EPS for the quarter, missing the consensus estimate of $3.75 by ($1.45). The business had revenue of $1.74 billion for the quarter, compared to the consensus estimate of $1.77 billion. Synopsys had a net margin of 31.04% and a return on equity of 10.82%. The business’s revenue was up 14.0% on a year-over-year basis. During the same quarter in the previous year, the firm posted $3.43 EPS. Synopsys has set its FY 2025 guidance at 12.760-12.800 EPS. Q4 2025 guidance at 2.760-2.80 EPS. On average, analysts anticipate that Synopsys, Inc. will post 10.64 EPS for the current year.

Synopsys Company Profile

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.